Retatrutide, 10mg

Retatrutide is a multi‑receptor incretin agonist that engages GLP‑1, GIP, and glucagon receptors. Researchers study it to interrogate appetite regulation, glucose homeostasis, and energy expenditure/biothermogenesis via glucagon co‑activation. Its broad mechanism enables head‑to‑head comparisons with single‑ or dual‑agonist incretin mimetics in metabolic research models. For laboratory research use only; not for human consumption.